Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gottlieb Leaves FDA Feeling Good About Generic Approvals, But Concerned About Innovative Competition

Executive Summary

In interview with the Pink Sheet, US FDA Commissioner Scott Gottlieb offers a final reflection of his time as commissioner.

You may also be interested in...



Sarepta, US FDA Offer Sparring Positions Over Release OF Complete Response Letters

Following Vyondys 53 rebuff, Sarepta CEO contends it would be "disrespectful" to release the complete response letter, while FDA contends that there is nothing stopping companies from publishing the letters.

Gottlieb Unleashed: Focus on Drug Pricing To Intensify As He Rejoins AEI

Without constraints of being FDA commissioner, Gottlieb will have podium to push for changes to drug pricing and competition.

Gottlieb Touts US FDA's Organizational Structure For Advancing Policies During His Tenure

Outgoing FDA commissioner said his direct contact with center directors helped agency advance policies and helped centers solve their problems.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1133951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel